In line with RNA-seq and Go analysis, Western blot analysis validated these changes in gene expression, and revealed a moderate increase of E-cadherin and/or decrease of Vimentin in USP22−/− cancer cells that reflects suppression of EMT singaling pathway (Fig. 2c). This evidence concerns the gene USP22 and cancer.